65 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would … of shares subject to any lien, after payment of the costs, shall be applied:
first, in or towards satisfaction of so much of the amount due to the Company
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
of a single transferee or no more than four joint transferees;
it is duly stamped or is duly certificated or otherwise shown to the satisfaction … as the depositary may deem reasonably appropriate, subject however, in each case, to satisfaction of the applicable registration requirements
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
to their satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement, and (2 … , shall be applied:
first, in or towards satisfaction of so much of the amount due to the Company or of the liability or engagement (as the case may
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
of a single transferee or no more than four joint transferees;
it is duly stamped or is duly certificated or otherwise shown to the satisfaction … and conditions as the depositary may deem reasonably appropriate, subject however, in each case, to satisfaction of the applicable registration requirements
10-K
2023 FY
EX-10.13
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
such failure to the Board’s reasonable satisfaction in its sole discretion; (iii) Executive’s committing any act which constitutes a breach of fiduciary duty … such failure to Board’s reasonable satisfaction in its sole discretion; (v) Executive’s material breach of any provision of this Agreement, any other
10-K
EX-10.14
8fug3eplqmk
28 Feb 24
Annual report
7:33am
10-K
EX-10.12
hki3pwtk2
28 Feb 24
Annual report
7:33am
10-K
5h6fduq
28 Feb 24
Annual report
7:33am
8-K
EX-99.1
1ft2zipaok7jps0ha
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
EX-4.1
8d9fjrt9yz
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
EX-99.1
jq87 2in778
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
6-K
EX-99.4
zcm54l v1z95xwk
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
gptph
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-1.1
3vtz7z9o15a55cnwmlb
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
a050cc5 cddhsx0uiii
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
ptk8 wy45l4l1
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
ocns0c3
20 Jul 22
Securities Purchase Agreement
4:06pm
424B7
upkp4
5 May 22
Prospectus with selling stockholder info
12:00am
F-3ASR
EX-4.7
x8nrbw o69j
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
F-3ASR
c7hh1 x75pc8stne05xj
4 Apr 22
Automatic shelf registration (foreign)
4:08pm